Home
Market
IPO
Screener
Bundles
Super Investors
Sector
Discover
TickerPlus
Account
Integris Medtech
Consolidated
Standalone
Peers
P&L
Balance Sheet
Cash Flows
Corp. Action
News
Ticker
>
Company
>
Integris Medtech share price
Integris Medtech Ltd.
308
0
0
The company is currently not listed and is under IPO, so all the data might not be available.
Peer Comparison
View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.
Ratios
Sales Growth
1 Year
-34.25%
3 Year
NA
5 Year
NA
Profit Growth
1 Year
16.61%
3 Year
NA
5 Year
NA
ROE%
1 Year
3.81%
3 Year
3.88%
ROCE %
1 Year
4.06%
3 Year
4.45%
Debt/Equity
0.0006
Price to Cash Flow
0
Interest Cover Ratio
0
CFO/PAT
(5 Yr. Avg.)
0
Strengths
The company has significantly decreased its debt by
85.0268
Cr.
Company is virtually debt free.
The company has an efficient Cash Conversion Cycle of
0
days.
Limitations
The company has shown a poor profit growth of
0
% for the Past 3 years.
The company has shown a poor revenue growth of
0
% for the Past 3 years.
Company has a poor ROE of
3.8819
% over the past 3 years.
Company has a poor ROCE of
4.44573333333333
% over the past 3 years
Company has contingent liabilities of
316.21
Cr.
Company has negative cash flow from operations of
-66.0672
.
The company has a low EBITDA margin of
0
% over the past 5 years.
Profit & Loss
(All Figures in Cr. Adjusted EPS in Rs.)
PARTICULARS
Mar 2023
Mar 2024
Mar 2025
Net Sales
62.7
58.31
38.34
Total Expenditure
61.74
57.69
44.97
Operating Profit
0.96
0.62
-6.63
Other Income
23.63
45.8
52.57
Interest
0.23
9.35
0.99
Depreciation
0.1
0.1
0.14
Exceptional Items
-2.64
-3.02
-4.58
Profit Before Tax
21.62
33.94
40.23
Tax
1.6
3.55
4.79
Net Profit
20.02
30.39
35.44
Adjusted EPS (Rs.)
4
6.07
6.01
Balance Sheet
(All Figures are in Crores.)
Particulars
Mar 2023
Mar 2024
Mar 2025
Equity and Liabilities
Share Capital
1.67
65.14
1.97
Total Reserves
632.85
663.24
1214.59
Borrowings
0
83.53
0
Other N/C liabilities
-0.49
0.17
18.69
Current liabilities
61.56
25.23
7.59
Total Liabilities
695.59
837.31
1242.83
Assets
Net Block
0.38
0.42
0.98
Capital WIP
0
0
0
Intangible WIP
0
0
0
Investments
574.29
678.21
517.56
Loans & Advances
84.74
92.34
79.21
Other N/C Assets
2.63
0
32.57
Current Assets
33.55
66.35
612.51
Total Assets
695.59
837.31
1242.83
* Other Non-current Liabilities include Net deferred Liabilities
Cash Flows
(All Figures are in Crores.)
PARTICULARS
Mar 2024
Mar 2025
Profit from operations
33.94
40.23
Adjustment
-34.15
-45.25
Changes in Assets & Liabilities
-11.07
-58.08
Tax Paid
-2.49
-2.97
Operating Cash Flow
-13.76
-66.07
Investing Cash Flow
-120.05
-276.36
Financing Cash Flow
125.13
352.19
Net Cash Flow
-8.69
9.77
Corporate Actions
Dividend
Bonus
Rights
Split
Company News
Integris Medtech gets SEBI’s approval to float IPO
24 Feb, 2:39 PM
Last Updated on:
Brief about Integris Medtech
x
Ratio Delete Confirmation
×
Are you sure you want to DELETE
from your ratio list? This will also hide it from all other companies that you analyze.
X